Peptide Hormones

Name
Peptide Hormones
Accession Number
DBCAT000055
Description

Hormones synthesized from amino acids. They are distinguished from INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS in that their actions are systemic.

Drugs
DrugDrug Description
.gamma.-brain natriuretic peptideNot Annotated
AbaloparatideA parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in patients with a high risk of fracture.
AclerastideAclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.
AdrenomedullinAdrenomedullin is under investigation in clinical trial NCT06072118 (Adrenomedullin for CADASIL).
AlbusomatropinAlbusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.
AlsactideNot Annotated
AmlintideA medication used in combination with corticosteroids for the treatment of hemorrhoids.
AnamorelinInvestigated for use/treatment in cachexia and anorexia.
AnaritideNot Annotated
Angiotensin 1-7TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
Angiotensin IIA peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock.
AOD9604Investigated for use/treatment in obesity and osteoporosis.
AP-102Not Annotated
AtilmotinAtilmotin is a small molecule drug. Atilmotin has a monoisotopic molecular weight of 1751.01 Da.
AtosibanAn inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations.
Atrial natriuretic peptideNot Annotated
AviptadilNot Annotated
BombesinBombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and...
BremelanotideBremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of...
BuserelinA LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females.
C-peptideC-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).
CagrilintideCagrilintide is under investigation in clinical trial NCT06221969 (A Research Study to See How Much Cagrisema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2...
CarbetocinAn oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth.
CargutocinCargutocin is a small molecule drug. Cargutocin has a monoisotopic molecular weight of 915.48 Da.
CenderitideCenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
CetrorelixA synthetic peptide antagonist of gonadotropin releasing hormone used to prevent luteinizing hormone surges in women undergoing assisted reproduction therapy.
Chorionic Gonadotropin (Human)A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women.
Corifollitropin alfaA FSH analogue indicated for Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.
CorticorelinA synthetic corticotropin-releasing factor analog used to diagnose causes of excessive adrenocorticotropic hormone (ACTH) production.
Corticorelin ovine triflutateA synthetic corticotropin-releasing hormone used for diagnostic purposes in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
CorticotropinA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
DasiglucagonA glucagon analog used to treat severe hypoglycemia in pediatric and adult patients with diabetes.
DemoxytocinNot Annotated
DeslorelinDeslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH agonist. It stops the production of sex hormones.
DesmopressinA synthetic vasopressin (antidiuretic hormone) analog and $V_2$ receptor agonist used as replacement therapy for central diabetes insipidus, and as a prohemostatic agent to increase Factor VIII and von Willebrand factor levels in patients with Hemophilia A or Type 1 von Willebrand disease.
DetirelixDetirelix is a small molecule drug. The usage of the INN stem '-relix' in the name indicates that Detirelix is a gonadotropin-releasing-hormone (GnRH) inhibitor. Detirelix has a monoisotopic molecular weight...
DopastatinDopastatin is under investigation in clinical trial NCT04335357 (TBR-760 in Adult Patients With Non-functioning Pituitary Adenomas).
DulaglutideA GLP-1 agonist used to manage type 2 diabetes mellitus.
EbiratideEbiratide is a small molecule drug. Ebiratide has a monoisotopic molecular weight of 995.53 Da.
Eftansomatropin alfaEftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
ElcatoninNot Annotated
FelypressinFor use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
FollitropinA form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism.
G17DT ImmunogenIntended for the treatment of various forms of cancer.
GanirelixA GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
Gastric inhibitory polypeptideGastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
GlucagonA form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures.
GonadorelinA synthetic GnRH used to test the function of gonadotropes and the pituitary.
GoserelinA synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.
HistrelinA GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
Indium In-111 pentetreotideIndium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome.
Insulin aspartA rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin degludecA long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus.
Insulin detemirA long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin glargineA modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus.
Insulin glulisineA short-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin humanA recombinant form of human insulin used to control hyperglycemia in diabetes mellitus.
Insulin icodecAn ultra long-acting basal insulin analogue for once-weekly injection in patients with diabetes mellitus.
Insulin lisproA modified form of fast-acting insulin used to control hyperglycemia in diabetes mellitus.
Insulin peglisproNot Annotated
Insulin porkA purified form of porcine insulin used to control hyperglycemia in diabetes mellitus.
IntermedineNot Annotated
LanreotideA somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly.
LenomorelinLenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.
LeptinInvestigated for use/treatment in lipodystrophy and obesity.
LiraglutideA GLP-1 analog used in the management of type 2 diabetes mellitus, prevention of cardiovascular complications associated with diabetes, and obesity.
LivoletideLivoletide is under investigation in clinical trial NCT03790865 (Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome).
LonapegsomatropinA human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion.
Luteinizing hormoneNot Annotated
LypressinNot Annotated
MenotropinsA purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility.
MetreleptinA leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy.
MinigastrinMinigastrin is under investigation in clinical trial NCT06155994 (68ga-dota-mgs5 PET/CT in Patients With Advanced Neuroendocrine Tumours).
MontirelinMontirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Montirelin is a thyrotropin releasing hormone analogue. Montirelin has a monoisotopic molecular...
NacartocinNacartocin is a small molecule drug. Nacartocin has a monoisotopic molecular weight of 985.51 Da.
NafarelinA gonadotropin releasing hormone agonist used to treat central precocious puberty.
NBI-6024Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
NesiritideA recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
NN344Investigated for use/treatment in diabetes mellitus type 1 and 2.
OrnipressinNot Annotated
OrotirelinOrotirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Orotirelin is a thyrotropin releasing hormone analogue. Orotirelin has a monoisotopic molecular...
Ostabolin-CInvestigated for use/treatment in menopause and osteoporosis.
OxytocinA recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding.
PalopegteriparatideA parathyroid hormone analog used to treat hyperparathyroidism in adults.
Pancreatic PolypeptidePancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.
Parathyroid hormoneAn analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism.
Parathyroid Hormone-Related Protein 1-36Parathyroid Hormone-Related Protein 1-36 is under investigation in clinical trial NCT00853723 (Comparison Study of Pthrp and PTH to Treat Osteoporosis).
PareptidePareptide is a small molecule drug. Pareptide has a monoisotopic molecular weight of 298.2 Da.
PasireotideA somatostatin analog used in the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery is not appropriate.
PegvisomantA growth hormone receptor antagonist used to treat acromegaly.
Pegylated synthetic human c-peptideNot Annotated
PentetreotideA somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours.
Peptide YY (1-36)Not Available
Peptide YY (3-36)Investigated for use/treatment in metabolic disease and obesity.
PirnabinePirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation.
PlecanatideA laxative used to treat chronic idiopathic constipation and IBS with constipation.
PosatirelinPosatirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Posatirelin is a thyrotropin releasing hormone analogue. Posatirelin has a monoisotopic molecular...
PramlintideAn amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
ProcalcitoninProcalcitonin is under investigation in clinical trial NCT03440060 (Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD).
ProgranulinNot Available
Proinsulin humanNot Annotated
ProtirelinA synthetic analogue of thyrotropin-releasing hormone that has been used during diagnostic tests to evaluate function of the thyroid gland.
Salmon calcitoninA synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease.
Secretin humanA secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts.
SelepressinSelepressin has been used in trials studying the treatment of Septic Shock.
SemaglutideA glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults.
SemparatideSemparatide is a small molecule drug. The usage of the INN stem '-paratide' in the name indicates that Semparatide is a parathyroid hormone analogue. Semparatide has a monoisotopic molecular weight...
SermorelinFor the treatment of dwarfism, prevention of HIV-induced weight loss
SetmelanotideA drug indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome.
SomapacitanA human growth hormone analog subcutaneous injection indicated for adults with growth hormone deficiency.
SomatorelinA synthetic version of growth hormone-releasing hormone used in the diagnosis of growth hormone deficiency.
SomatostatinA natural peptide hormone used to treat acute bleeding from esophageal varices, gastrointestinal ulcers, and gastritis; prevent pancreatic complications after surgery; and restrict secretions of the upper intestine, pancreas, and biliary tract.
SomatotropinA recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.
SomatremA recombinant growth hormone used to treat adult growth hormone deficiency and treat disrupted growth in children due to growth hormone insufficiency or deficiency, turner's syndrome, chronic renal failure, and small stature for gestational age.
SomatrogonA long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency.
Somatropin pegolSomatropin pegol is under investigation in clinical trial NCT00715689 (Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083).
TaltirelinTaltirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Taltirelin is a thyrotropin releasing hormone analogue. Taltirelin has a monoisotopic molecular...
TeriparatideA recombinant parathyroid hormone used for the treatment of osteoporosis.
TerlipressinA drug used to treat bleeding caused by esophageal varices.
TesamorelinA growth hormone releasing factor (GRF) analog used to reduce excessive abdominal fat in HIV patients who have developed lipodystrophy.
TetracosactideA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
ThymalfasinIndicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate...
ThyrotropinA medication indicated in thyroid stimulation before radioactive iodine ablation or for thyroid imaging.
Thyrotropin alfaA recombinant form of thyroid stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue.
TimbetasinTimbetasin is under investigation in clinical trial NCT05555589 (Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2).
TirzepatideA dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise.
TP-3654Not Annotated
TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
TT-232Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
UlaritideInvestigated for use/treatment in congestive heart failure.
Urocortin-2Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
UrofollitropinA form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure.
VapreotideFor the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.
Vasoactive intestinal peptideNot Annotated
VasomeraNot Available
VasopressinA peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy.
VeldoreotideSomatoprim is under investigation for the treatment of Acromegaly.
VosoritideAn analogue of C-type naturietic peptide used to promote bone growth in pediatric patients with achondroplasia.
Zoptarelin doxorubicinZoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
Drugs & Drug Targets
DrugTargetType
.gamma.-brain natriuretic peptideAtrial natriuretic peptide receptor 1target
AbaloparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
AclerastideProto-oncogene Mastarget
AdrenomedullinNeprilysinenzyme
AdrenomedullinCalcitonin gene-related peptide type 1 receptortarget
AlbusomatropinGrowth hormone receptortarget
AlsactideAdrenocorticotropic hormone receptortarget
AnamorelinGrowth hormone secretagogue receptor type 1target
AnamorelinNeutral alpha-glucosidase Ctarget
AnamorelinNeutral alpha-glucosidase ABtarget
AnamorelinLysosomal alpha-glucosidasetarget
Angiotensin 1-7Proto-oncogene Mastarget
Angiotensin IIType-2 angiotensin II receptortarget
Angiotensin IIType-1 angiotensin II receptortarget
AOD9604Growth hormone receptortarget
AP-102Somatostatin receptor type 2target
AP-102Somatostatin receptor type 5target
AtilmotinMotilin receptortarget
AtosibanVasopressin V2 receptortarget
AtosibanVasopressin V1b receptortarget
AtosibanVasopressin V1a receptortarget
AtosibanOxytocin receptortarget
Atrial natriuretic peptideAtrial natriuretic peptide receptor 3target
Atrial natriuretic peptideAtrial natriuretic peptide receptor 1target
Atrial natriuretic peptideNeprilysinenzyme
AviptadilVasoactive intestinal polypeptide receptor 1target
BombesinBombesin receptor subtype-3target
BombesinNeuromedin-B receptortarget
BombesinGastrin-releasing peptide receptortarget
BremelanotideMelanocortin receptor 5target
BremelanotideAdrenocorticotropic hormone receptortarget
BremelanotideMelanocortin receptor 3target
BremelanotideMelanocyte-stimulating hormone receptortarget
BremelanotideMelanocortin receptor 4target
BuserelinLutropin-choriogonadotropic hormone receptortarget
BuserelinGonadotropin-releasing hormone receptortarget
BuserelinAromataseenzyme
CagrilintideCalcitonin receptortarget
CarbetocinOxytocin receptortarget
CenderitideAtrial natriuretic peptide receptor 2target
CenderitideAtrial natriuretic peptide receptor 1target
CenderitideAtrial natriuretic peptide receptor 3target
CetrorelixGonadotropin-releasing hormone receptortarget
Chorionic Gonadotropin (Human)Lutropin-choriogonadotropic hormone receptortarget
Corifollitropin alfaFollicle-stimulating hormone receptortarget
CorticorelinCorticotropin-releasing hormone receptor 1target
CorticorelinDopamine beta-hydroxylaseenzyme
CorticorelinCorticotropin-releasing hormone receptor 2target
Corticorelin ovine triflutateCorticotropin-releasing hormone receptor 1target
Corticorelin ovine triflutateCorticotropin-releasing hormone receptor 2target
CorticotropinCorticotropin-releasing hormonetarget
CorticotropinCytochrome P450 3A4enzyme
Corticotropin1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialenzyme
Corticotropin25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialenzyme
Corticotropin3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
CorticotropinAdrenocorticotropic hormone receptortarget
DasiglucagonGlucagon receptortarget
DeslorelinGonadotropin-releasing hormone receptortarget
DesmopressinOxytocin receptortarget
DesmopressinProstaglandin G/H synthase 2enzyme
DesmopressinProstaglandin G/H synthase 1enzyme
DesmopressinVasopressin V2 receptortarget
DesmopressinVasopressin V1b receptortarget
DesmopressinVasopressin V1a receptortarget
DetirelixGonadotropin-releasing hormone receptortarget
DopastatinPolyunsaturated fatty acid 5-lipoxygenasetarget
DopastatinD(2) dopamine receptortarget
DopastatinSomatostatin receptor type 2target
DopastatinSomatostatin receptor type 5target
DulaglutideGlucagon-like peptide 1 receptortarget
FelypressinVasopressin V1a receptortarget
FollitropinFollicle-stimulating hormone receptortarget
GanirelixGonadotropin-releasing hormone receptortarget
Gastric inhibitory polypeptideGastric inhibitory polypeptide receptortarget
GlucagonGlucagon-like peptide 1 receptortarget
GlucagonGlucagon-like peptide 2 receptortarget
GlucagonGlucagon receptortarget
GonadorelinGonadotropin-releasing hormone receptortarget
GonadorelinPutative gonadotropin-releasing hormone II receptortarget
GoserelinLutropin-choriogonadotropic hormone receptortarget
GoserelinProgonadoliberin-1target
GoserelinGonadotropin-releasing hormone receptortarget
HistrelinGonadotropin-releasing hormone receptortarget
Indium In-111 pentetreotideSomatostatin receptortarget
Indium In-111 pentetreotideSomatostatin receptor type 2target
Insulin aspartInsulintarget
Insulin aspartCytochrome P450 1A2enzyme
Insulin aspartInsulin-like growth factor 1 receptortarget
Insulin aspartInsulin receptortarget
Insulin degludecInsulin-like growth factor 1 receptortarget
Insulin degludecInsulin receptortarget
Insulin degludecAlbumincarrier
Insulin degludecCytochrome P450 1A2enzyme
Insulin degludecInsulin-degrading enzymeenzyme
Insulin degludecInsulintarget
Insulin detemirInsulintarget
Insulin detemirInsulin-degrading enzymeenzyme
Insulin detemirCytochrome P450 1A2enzyme
Insulin detemirInsulin-like growth factor 1 receptortarget
Insulin detemirAlbumincarrier
Insulin detemirInsulin receptortarget
Insulin glargineInsulin receptortarget
Insulin glargineInsulin-like growth factor 1 receptortarget
Insulin glargineCytochrome P450 1A2enzyme
Insulin glargineInsulintarget
Insulin glulisineCytochrome P450 1A2enzyme
Insulin glulisineInsulin receptortarget
Insulin glulisineInsulin-like growth factor 1 receptortarget
Insulin humanInsulin-like growth factor-binding protein 7target
Insulin humanInsulin receptortarget
Insulin humanInsulin-like growth factor 1 receptortarget
Insulin humanInsulin-degrading enzymeenzyme
Insulin humanNeuroendocrine convertase 2enzyme
Insulin humanNeuroendocrine convertase 1enzyme
Insulin humanCytochrome P450 1A2enzyme
Insulin humanCarboxypeptidase Etarget
Insulin humanCCN family member 3target
Insulin humanLow-density lipoprotein receptor-related protein 2target
Insulin icodecInsulin-degrading enzymeenzyme
Insulin icodecAlbumincarrier
Insulin icodecInsulin-like growth factor 1 receptortarget
Insulin icodecInsulin receptortarget
Insulin lisproInsulin-degrading enzymeenzyme
Insulin lisproCytochrome P450 1A2enzyme
Insulin lisproInsulin-like growth factor 1 receptortarget
Insulin lisproInsulin receptortarget
Insulin peglisproCytochrome P450 1A2enzyme
Insulin peglisproInsulin receptortarget
Insulin peglisproInsulin-like growth factor 1 receptortarget
Insulin peglisproInsulintarget
Insulin porkInsulin receptortarget
Insulin porkInsulin-like growth factor 1 receptortarget
Insulin porkCytochrome P450 1A2enzyme
Insulin porkInsulin-degrading enzymeenzyme
LanreotideCytochrome P450 3A4enzyme
LanreotideSomatostatin receptor type 5target
LanreotideSomatostatin receptor type 2target
LenomorelinGrowth hormone secretagogue receptor type 1target
LeptinLeptin receptortarget
LiraglutideAlbumincarrier
LiraglutideNeprilysinenzyme
LiraglutideDipeptidyl peptidase 4enzyme
LiraglutideGlucagon-like peptide 1 receptortarget
LivoletideGrowth hormone secretagogue receptor type 1target
Lonapegsomatropin11-beta-hydroxysteroid dehydrogenase 1enzyme
LonapegsomatropinGrowth hormone receptortarget
LonapegsomatropinProlactin receptortarget
LonapegsomatropinCytochrome P450 1A2enzyme
LonapegsomatropinCytochrome P450 2C19enzyme
LonapegsomatropinATP-dependent translocase ABCB1transporter
Luteinizing hormoneLutropin-choriogonadotropic hormone receptortarget
LypressinVasopressin V1a receptortarget
LypressinVasopressin V2 receptortarget
LypressinVasopressin V1b receptortarget
LypressinATP-binding cassette sub-family C member 2transporter
MenotropinsFollicle-stimulating hormone receptortarget
MenotropinsLutropin-choriogonadotropic hormone receptortarget
MetreleptinLeptin receptortarget
MinigastrinGastrin/cholecystokinin type B receptortarget
MontirelinThyrotropin-releasing hormone receptortarget
NafarelinPutative gonadotropin-releasing hormone II receptortarget
NafarelinGonadotropin-releasing hormone receptortarget
NesiritideAtrial natriuretic peptide receptor 3target
NesiritideAtrial natriuretic peptide receptor 1target
NesiritideAtrial natriuretic peptide receptor 2target
NN344Cytochrome P450 1A2enzyme
NN344Insulin receptortarget
OrnipressinVasopressin V1a receptortarget
Ostabolin-CParathyroid hormone/parathyroid hormone-related peptide receptortarget
OxytocinProlyl endopeptidaseenzyme
OxytocinVasopressin V2 receptortarget
OxytocinVasopressin V1b receptortarget
OxytocinVasopressin V1a receptortarget
OxytocinAdvanced glycation end product-specific receptortransporter
OxytocinLeucyl-cystinyl aminopeptidaseenzyme
OxytocinOxytocin-neurophysin 1 proproteincarrier
OxytocinOxytocin receptortarget
PalopegteriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
Pancreatic PolypeptideNeuropeptide Y receptor type 4-2target
Pancreatic PolypeptideNeuropeptide Y receptor type 4target
Parathyroid hormoneParathyroid hormone 2 receptortarget
Parathyroid hormoneParathyroid hormone/parathyroid hormone-related peptide receptortarget
PasireotideSomatostatin receptor type 1target
PasireotideCytochrome P450 3A4enzyme
PasireotideSomatostatin receptor type 2target
PasireotideSomatostatin receptor type 5target
PasireotideSomatostatin receptor type 3target
PegvisomantCytochrome P450 4A11enzyme
PegvisomantCholinesteraseenzyme
PegvisomantGrowth hormone receptortarget
PegvisomantCytochrome P450 3A4enzyme
PegvisomantGlutamine synthetaseenzyme
PegvisomantSterol 26-hydroxylase, mitochondrialenzyme
PentetreotideSomatostatin receptortarget
PentetreotideSomatostatin receptor type 5target
PentetreotideSomatostatin receptor type 2target
Peptide YY (1-36)Neprilysinenzyme
Peptide YY (1-36)Xaa-Pro aminopeptidase 1enzyme
Peptide YY (1-36)Dipeptidyl peptidase 4enzyme
Peptide YY (1-36)Neuropeptide Y receptor type 5target
Peptide YY (1-36)Neuropeptide Y receptor type 4target
Peptide YY (1-36)Neuropeptide Y receptor type 2target
Peptide YY (1-36)Neuropeptide Y receptor type 1target
Peptide YY (3-36)Neuropeptide Y receptor type 2target
Peptide YY (3-36)Neuropeptide Y receptor type 1target
Peptide YY (3-36)Neuropeptide Y receptor type 5target
Peptide YY (3-36)Neuropeptide Y receptor type 4target
PlecanatideGuanylyl cyclase Ctarget
PosatirelinThyrotropin-releasing hormone receptortarget
PramlintideCalcitonin receptortarget
PramlintideReceptor activity-modifying protein 3target
PramlintideReceptor activity-modifying protein 2target
PramlintideReceptor activity-modifying protein 1target
PramlintideGlucagon-like peptide 1 receptortarget
ProtirelinThyrotropin-releasing hormone receptortarget
Salmon calcitoninCalcitonin receptortarget
Secretin humanSecretin receptortarget
Secretin humanSecretintarget
SelepressinVasopressin V1a receptortarget
SemaglutideLipoprotein lipaseenzyme
SemaglutideGlucagon-like peptide 1 receptortarget
SemaglutideNeprilysinenzyme
SemaglutideDipeptidyl peptidase 4enzyme
SemaglutideAlbumincarrier
SemparatideParathyroid hormone 2 receptortarget
SermorelinGrowth hormone-releasing hormone receptortarget
SetmelanotideMelanocortin receptor 4target
SomapacitanGrowth hormone receptortarget
SomapacitanAlbumincarrier
SomapacitanCytochrome P450 2C19enzyme
SomapacitanCytochrome P450 1A2enzyme
SomapacitanCytochrome P450 2C12, female-specificenzyme
Somapacitan11-beta-hydroxysteroid dehydrogenase 1enzyme
SomatorelinGrowth hormone-releasing hormone receptortarget
SomatostatinSomatostatin receptor type 3target
SomatostatinSomatostatin receptortarget
SomatostatinDelta-type opioid receptortarget
SomatostatinMu-type opioid receptortarget
SomatostatinCytochrome P450 3A4enzyme
SomatostatinATP-dependent translocase ABCB1transporter
SomatostatinSomatostatin receptor type 5target
SomatostatinSomatostatin receptor type 4target
SomatostatinSomatostatin receptor type 2target
SomatostatinSomatostatin receptor type 1target
SomatotropinATP-dependent translocase ABCB1transporter
SomatotropinCytochrome P450 2C19enzyme
SomatotropinCytochrome P450 1A2enzyme
SomatotropinProlactin receptortarget
SomatotropinGrowth hormone receptortarget
SomatremGrowth hormone receptortarget
SomatremInsulin-like growth factor 1 receptortarget
SomatrogonGrowth hormone receptortarget
Somatropin pegolGrowth hormone receptortarget
TaltirelinThyrotropin-releasing hormone receptortarget
TeriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
TeriparatideParathyroid hormonetarget
TerlipressinVasopressin V1b receptortarget
TerlipressinVasopressin V2 receptortarget
TerlipressinVasopressin V1a receptortarget
TesamorelinGrowth hormone-releasing hormone receptortarget
TetracosactideAdrenocorticotropic hormone receptortarget
ThymalfasinToll-like receptor 9target
ThymalfasinAngiotensin-converting enzymetarget
ThyrotropinThyrotropin receptortarget
Thyrotropin alfaThyrotropin receptortarget
TirzepatideGlucagon-like peptide 1 receptortarget
TirzepatideAlbumincarrier
TirzepatideGastric inhibitory polypeptide receptortarget
TP-3654Serine/threonine-protein kinase pim-2target
TP-3654Serine/threonine-protein kinase pim-3target
TP-3654Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
TP-3654Serine/threonine-protein kinase pim-1target
TriptorelinGonadotropin-releasing hormone receptortarget
TT-232Pyruvate kinase PKMtarget
UlaritideAtrial natriuretic peptide receptor 1target
Urocortin-2Corticotropin-releasing hormone receptor 2target
UrofollitropinFollicle-stimulating hormone receptortarget
VapreotideCytochrome P450 3A4enzyme
VapreotideSomatostatin receptor type 5target
VapreotideSomatostatin receptor type 2target
VapreotideSubstance-P receptortarget
VapreotideSomatostatin receptor type 3target
Vasoactive intestinal peptideVasoactive intestinal polypeptide receptor 1target
Vasoactive intestinal peptideAlpha adrenergic receptortarget
VasomeraVasoactive intestinal polypeptide receptor 2target
VasomeraVasoactive intestinal polypeptide receptor 1target
VasopressinOxytocin receptortarget
VasopressinATP-binding cassette sub-family C member 2transporter
VasopressinVasopressin V1b receptortarget
VasopressinVasopressin V2 receptortarget
VasopressinVasopressin V1a receptortarget
VeldoreotideSomatostatin receptor type 2target
VeldoreotideSomatostatin receptor type 4target
VeldoreotideSomatostatin receptor type 5target
VosoritideAtrial natriuretic peptide receptor 2target
Zoptarelin doxorubicinGonadotropin-releasing hormone receptortarget